Dr. Gerald A. Hladik, MD

Dr. Hladik practices at Fmc Mebane in Burlington, North Carolina.

Dr. Hladik's NPI, 1467566075, was assigned on August 19, 2006. Dr. Hladik graduated from Boston University School Of Medicine in 1989. Dr. Hladik holds North Carolina license 35371.

Dr. Hladik's primary practice is Fmc Mebane, at 2903 Professional Park Dr, Burlington, NC 27215 in Alamance County. The practice phone is (919) 563-2304.

Dr. Hladik's primary practice is Fmc Mebane in Burlington, North Carolina. Dr. Hladik is also affiliated with UNC Hospitals. The medical group on file is UNC Faculty Physicians. Dmand AI also links Dr. Hladik to 3 more hospitals, 2 medical groups, 1 dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hladik practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Hladik's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Hladik is board certified in internal medicine by the American Board of Internal Medicine. Dr. Hladik is licensed in North Carolina.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances and parathyroid gland disorder among the conditions Dr. Hladik treats.

CMS data shows 495 Medicare services from Dr. Hladik across 8 procedure codes in 2024, for 154 Medicare patients. Medicare paid $54,417 for them.

CMS counts 154 Medicare patients who saw Dr. Hladik in 2024. The largest group is 65 to 74, with 54 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 25% are also on Medicaid. Their average risk score is 4.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hladik's median patient age at 68, with 46% women.

In 2024, Dr. Hladik wrote 1,935 Medicare Part D claims for 178 patients. 86% of them were for generic drugs. CMS names the drug for 1,435 of them, across 51 drugs with 11 or more claims each, at $380,377 in total drug cost. In 2023, CMS named 1,005 claims across 39 drugs.

Dr. Hladik accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hladik as offering telehealth.

Dmand AI links 22 papers to Dr. Hladik, published from 2013 to 2025. 2015 was the busiest year, with 5. The most frequent topics are Renal Dialysis, Kidney Failure, Chronic and Advance Care Planning. Dr. Hladik has published most often in Am J Kidney Dis. Dr. Hladik's most frequent co-authors are Laura C. Hanson, MD, Michael C. Beuhler, MD and Koyal Jain, MD.

CMS Open Payments shows 10 general payments to Dr. Hladik from 4 drug and device companies from 2017 to 2023. Consulting fees make up the largest share, 75% of the total. Fresenius USA Marketing, Inc. paid the most, $5,574.

Dmand AI lists 1 award for Dr. Hladik, most recently Regional Top Doctor in 2014.

Dr. Hladik graduated from Boston University School Of Medicine in 1989.

Dr. Hladik is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.